Minipig Model of Huntington´s Disease: 1H Magnetic Resonance Spectroscopy of the Brain
Authors:
- V. HerynekVHV. Herynek
- F. JiruFJF. Jiru
- M. DezortovaMDM. Dezortova
- J. JuhasovaJJJ. Juhasova
- S. JuhasSJS. Juhas
- J. MotlikJMJ. Motlik
- M. HajekMHM. Hajek
- 14 February 2016
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 65 (1) , 155-163
Abstract
Huntington’s disease (HD) is an inherited autosomal neurodegenerative disorder affecting predominantly the brain, characterized by motor dysfunctions, behavioral and cognitive disturbances. The aim of this study was to determine changes in the brain of transgenic minipigs before HD onset using 1H magnetic resonance (MR) spectroscopy. Measurements were performed on a 3 T MR scanner using a single voxel spectroscopy sequence for spectra acquisition in the white matter and chemical shift imaging sequence for measurement in the striatum, hippocampus and thalamus. A decrease of (phospho)creatine (tCr) concentration was found only in the thalamus (p=0.002) of transgenic minipigs, nevertheless we found significant changes in metabolite ratios. Increase of the ratio choline compounds (tCho)/tCr was found in all examined areas: striatum (p=0.010), thalamus (p=0.011) as well as hippocampus (p=0.027). The ratio N-acetylaspartate+N-acetylaspartylglutamate (tNAA)/tCr (p=0.043) and glutamate+glutamine (Glx)/tCr (p=0.039) was elevated in the thalamus, the ratio myo-inositol (Ins)/tCr (p=0.048) was significantly increased in the hippocampus. No significant differences were observed in the metabolite concentrations in the white matter, however we found significant increase of ratios tNAA/tCr (p=0.018) and tCho/tCr (p=0.003) ratios in transgenic boars. We suppose that the majority of the observed changes are predominantly related to changes in energy metabolism caused by decrease of tCr.Keywords
This publication has 27 references indexed in Scilit:
- jSIPRO – Analysis tool for magnetic resonance spectroscopic imagingComputer Methods and Programs in Biomedicine, 2013
- Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's DiseasePLOS ONE, 2012
- Brain metabolite alterations and cognitive dysfunction in early Huntington's diseaseMovement Disorders, 2012
- The Search for Sensitive Biomarkers in Presymptomatic Huntington DiseaseJournal of Cerebral Blood Flow & Metabolism, 2012
- Neurodegenerative processes in Huntington's diseaseCell Death & Disease, 2011
- Cortical Metabolites as Biomarkers in the R6/2 Model of Huntington's DiseaseJournal of Cerebral Blood Flow & Metabolism, 2011
- Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolismJournal of Neurology, 2011
- Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington diseaseNeurology, 2010
- Quantitative Proton Magnetic Resonance Spectroscopy of Childhood AdrenoleukodystrophyNeuropediatrics, 1998
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993